The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally
CARLSBAD, Calif., June 2, 2026 /PRNewswire/ -- As laboratories increasingly seek faster, more cost-efficient alternatives to legacy single-analyte testing, demand for scalable multi-analyte proteomic workflows is growing across pharma, reference laboratory, and animal health markets. Today marks one year since Pictor Holdings Inc., a global targeted proteomic platform company founded in New Zealand, opened its U.S. headquarters in Carlsbad, California.